Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
West · Colorado
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Colorado Springs (490,000 residents, 770,000 metro). Large military and veteran population shapes the local market; Health First Colorado covers T2D GLP-1s with prior auth.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Colorado Springs →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Colorado Springs →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Colorado Springs →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Colorado Springs →
Colorado Springs is a west-region city with a population of 490,000 (770,000 in the broader metropolitan area). Colorado expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include UCHealth, Denver Health, National Jewish Health.
Colorado's Medicaid program is Health First Colorado. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.